Third Wave wins triple damages in patent case
A federal judge has tripled
Third Wave Technologies' compensation in a patent lawsuit with rival
Stratagene to $15.9 million plus legal fees. Stratagene is proceeding with its appeal.
The lawsuit was decided in September after the judge found that Stratagene
willfully infringed on two patents covering molecular diagnostics methods, and awarded Madison-based Third Wave $5.3 million.
Third Wave uses the technology in its Invader line of products. Stratagene was given an injunction in September preventing it from selling its FullVelocity QPCR and QRT-PCR systems.